Pretreatment of mice with granulocyte-macrophage colony-stimulating factor (GM-CSF) had no discernible impact on the development of septic arthritis, despite an increase in the total number of leukocytes and the granulocyte fraction. Here, CSF2 is linked to bacterial arthritis.